Radiation Therapy
Phase 2Small molecule
Radiation Therapy is one of 122 small molecule programs targeting Lymphoma. It is currently in Phase 2.
5
Indications
7
Total Trials
5
Active Trials
121
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1774 competitors in Lymphoma
#DrugCompanyPhaseTrials
1Radiation Therapy
MM.D. Anderson Cancer Center
Phase 2
Velban
EEastern Cooperative Oncology Group
Preclinical
Oncaspar
SServier
Preclinical
Zofran
NovartisPreclinical
Norvir
AbbViePreclinical
Wellcovorin
GGlaxo Dba Glaxosmithkline
Preclinical
Tafasitamab
IncytePreclinical
Nuvigil
NNuvo Research GmbH
Preclinical
Elitek
AAzienda U.S.L. 1 di Massa e Carrara
Preclinical
Solu-Medrol
MMassachusetts Eye and Ear Infirmary
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Multiple Myeloma1 trial
MALT lymphoma1 trial
Radiation Therapy1 trial
A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC
Active, not recruiting·—·Phase 2·NCT02905591·43 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Radiation Therapy. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 2[1]
- Company
- MM.D. Anderson Cancer Center